Skip to content

Adductor Canal Block Versus Liposomal Bupivacaine in TKA

Clinical Outcomes of an Adductor Canal Block Versus Liposomal Bupivacaine in Total Knee Arthroplasty Patients: A Randomized Prospective Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04086186
Enrollment
60
Registered
2019-09-11
Start date
2017-03-22
Completion date
2018-12-18
Last updated
2019-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Pain Control, Total Knee Arthroplasty

Brief summary

This is a randomized prospective study of 60 patients undergoing total knee arthroplasty evaluating the clinical outcomes of liposomal bupivacaine periarticular injections (PAI) when compared to single shot adductor canal block using bupivacaine HCl.

Detailed description

Total knee arthroplasty(TKA) is an effective solution for end stage arthritis of the knee; however, post-surgical pain can be difficult to manage and the optimal peri-operative pain management strategy has not been established. This study serves to evaluate the clinical outcomes of liposomal bupivacaine PAI when compared to single shot adductor canal block using bupivacaine HCl in patients undergoing a TKA. The investigators hypothesized that peri-articular injection with liposomal bupivacaine would not be inferior to an adductor canal block using bupivacaine HCl. A total of 60 patients were recruited. Thirty patients were randomized to receive intraoperative liposomal bupivacaine periarticular injection, and another thirty patients randomized to receive a pre-operative adductor canal block using bupivacaine. Both groups otherwise received standard pain management strategies peri-operatively. The primary outcome of interest was post-operative pain, which was measured using the Visual Analog Scale (VAS). Secondary measures included changes in patient function which was measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), knee range of motion, post-operative ambulation distance, and hospital length of stay.

Interventions

PROCEDURELiposomal Bupivacaine Peri-articular Injection

A 20mL solution of 266mg of liposomal bupivacaine (Exparel) was mixed with 40mL of normal saline, which was then infiltrated consistently in the posterior capsule, medial and lateral side of the arthrotomy, patella tendon, quadriceps tendon, quadriceps musculature, and subcutaneous soft tissue.

PROCEDUREAdductor canal block

Anesthesiologist performs preoperative adductor canal block using 15mL of 0.5% Bupivacaine HCl

Sponsors

Good Samaritan Regional Medical Center, Oregon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients undergoing unilateral primary total knee arthroplasty for end stage osteoarthritis or rheumatoid arthritis. 2. All adults \> 18 years of age.

Exclusion criteria

1. Not cleared by PCP and appropriate specialists to undergo TKA (Check No if patient has been cleared.) 2. Adults undergoing bilateral primary total knee arthroplasties. 3. Women who are pregnant. 4. Women who are breastfeeding. 5. Inability to receive successful spinal anesthesia. 6. Allergy to amide anesthetics. 7. Inability to receive IV tranexamic acid. 8. Patients who are unable to speak English. 9. Patients who are less than 66kg. 10. Patients who are opioid dependent. We define opioid dependency as patients who are on a long-acting narcotic or patients who are taking more than six tablets of hydrocodone 5mg or equivalent.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)VAS pain score on post-operative day #1Visual analog pain scale ranges from zero (no pain) to 10 (maximum pain)

Secondary

MeasureTime frameDescription
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Outcome measure will be assessed up to 8 weeksReported WOMAC Score ranges between 0 (worst) to 100 (best)
Knee range of motionOutcome measure will be assessed up to 8 weeksKnee flexion and extension will be recorded during follow up visits
Ambulation distance after surgeryRecorded on post-operative day #1Distance walked in feet will be assessed and recorded by physical therapist
Hospital length of stayMeasure outcome will be assess through study completion, on average of 1 yearMeasured by number of nights patient stayed in hospital after surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026